The plateau represents the maximum binding capacity, or Bmax, reached when the available receptor sites are occupied. The ligand concentration corresponding to half of that maximum provides an estimate of Kd, the dissociation constant. Together, these curve features separate receptor availability from binding strength, allowing researchers to characterize both how many sites are present and how strongly the ligand interacts with them.
Because the biological preparation contains a finite population of receptors, binding cannot increase indefinitely as labeled ligand concentration rises. Once available sites become occupied, additional ligand produces little further receptor-associated binding, creating the characteristic plateau. This finite-site behavior makes it possible to estimate receptor density or availability rather than merely observing that ligand-receptor interaction occurs.
Specific binding reflects labeled ligand associated with the receptors of interest, whereas nonspecific binding represents other associations within the biological preparation. Distinguishing these components prevents total ligand-associated signal from being interpreted as receptor binding alone. This separation is important when estimating Bmax and Kd because both parameters are intended to describe the receptor interaction rather than unrelated ligand associations.
Researchers prepare a biological sample containing the receptors, expose it to progressively higher concentrations of labeled ligand, and incubate each condition so binding can occur. They then assess the resulting ligand-associated binding across the concentration range and construct a binding curve. The curve is analyzed for its plateau and half-maximal point to estimate Bmax and Kd.
A saturation binding curve provides two complementary measurements: Bmax indicates the maximum receptor-associated binding supported by the preparation, while Kd estimates the ligand concentration needed to reach half of that capacity. Examining both values helps distinguish changes in receptor availability from differences in binding strength, which is useful when characterizing biological samples in medicine and drug research.
In medicine and drug research, the assay helps characterize receptors that may serve as therapeutic targets and supports evaluation of candidate compounds. By estimating receptor availability and ligand binding strength, researchers can compare the interaction properties of a compound with the receptor system under study. The results provide a quantitative basis for investigating receptor biology and drug-target relationships.